Accendra Health, Inc. Additional Paid in Capital, Common Stock
Accendra Health, Inc. (ACH) had Additional Paid in Capital, Common Stock of $471.59 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-10
- 2026-06-30: Additional Paid in Capital, Common Stock $471.59M.
- 2026-03-31: Additional Paid in Capital, Common Stock $469.09M.
- 2025-12-31: Additional Paid in Capital, Common Stock $466.88M.
- 2025-09-30: Additional Paid in Capital, Common Stock $468.47M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $471.59M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $469.09M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $466.88M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $468.47M 10-Q · filed 2025-10-31 |
| 2025-06-30 | $466.70M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $459.73M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $454.15M 10-K · filed 2026-02-20 |
| 2024-09-30 | $445.75M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $440.44M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $438.59M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $434.19M 10-K · filed 2025-02-28 |
| 2023-09-30 | $427.89M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $421.99M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $420.68M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $418.89M 10-K · filed 2024-02-20 |
| 2022-09-30 | $413.89M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $407.77M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $409.74M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $440.61M 10-K · filed 2023-02-28 |
| 2021-09-30 | $434.95M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $428.36M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $430.49M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $436.60M 10-K · filed 2022-02-23 |
| 2020-09-30 | $262.00M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $258.73M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $256.36M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $251.40M 10-K · filed 2021-02-24 |
| 2019-09-30 | $248.92M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $244.76M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $241.55M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $238.77M 10-K · filed 2020-03-04 |
| 2018-09-30 | $233.92M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $229.88M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $228.27M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $226.94M 10-K · filed 2019-03-06 |
| 2017-09-30 | $224.18M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $221.68M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $220.61M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $219.96M 10-K · filed 2018-02-23 |
| 2016-09-30 | $216.87M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $214.44M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $213.02M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $211.94M 10-K · filed 2017-02-17 |
| 2015-09-30 | $208.22M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $205.73M 10-Q · filed 2015-07-28 |
| 2015-03-31 | $204.90M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $202.93M 10-K · filed 2016-02-25 |
| 2014-09-30 | $200.96M 10-Q · filed 2014-10-29 |
| 2014-06-30 | $199.02M 10-Q · filed 2014-07-30 |
| 2014-03-31 | $199.15M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $196.60M 10-K · filed 2015-02-23 |
| 2013-09-30 | $194.76M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $192.33M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $190.00M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $187.39M 10-K · filed 2014-02-25 |
| 2012-09-30 | $185.69M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $184.63M 10-Q · filed 2012-07-27 |
| 2012-03-31 | $183.39M 10-Q · filed 2012-04-27 |
| 2011-12-31 | $179.05M 10-K · filed 2013-02-22 |
| 2011-09-30 | $176.54M 10-Q · filed 2011-10-28 |
| 2011-06-30 | $175.17M 10-Q · filed 2011-07-29 |
| 2011-03-31 | $172.03M 10-Q · filed 2011-04-29 |
| 2010-12-31 | $165.45M 10-K · filed 2012-02-24 |
| 2010-09-30 | $162.81M 10-Q · filed 2010-10-29 |
| 2010-06-30 | $161.78M 10-Q · filed 2010-07-30 |
| 2009-12-31 | $193.91M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |